Skip to main content Accessibility help

Long-Term Central Venous Catheter Infection in HIV-infected and Cancer Patients: A Multicenter Cohort Study

  • Pascal Astagneau (a1), Sylvie Maugat (a1), Tuan Tran-Minh (a1), Marie-Cécile Douard (a2), Pascale Longuet (a2), Caroline Maslo (a2), Régis Parte (a2), Annick Macrez (a2) and Gilles Brücker (a1) (a2)...



To evaluate and compare the risk of long-term central venous catheter (CVC) infection in human immunodeficiency virus (HIV)-infected and cancer patients.


Prospective multicenter cohort study based on active surveillance of long-term CVC manipulations and patient outcome over a 6-month period.


Services of infectious diseases and oncology of 12 university hospitals in Paris, France.


In 1995, all HIV and cancer patients with solid malignancy were included at the time of long-term CVC implantation.


Overall, 31.6% of long-term CVC infections were identified in 32% of 201 HIV and 5% of 255 cancer patients. Most were associated with bacteremia, most commonly coagulase-negative staphylococci. The long-term CVC time-related infection risk was greater in HIV than in cancer patients (3.78 vs 0.39 infections per 1,000 long-term CVC days; P<.001). The independent risk factors of long-term CVC infection were as follows: in HIV patients, frequency of long-term CVC handling and neutropenia; in cancer patients, poor Karnofsky performance status; in both HIV and cancer patients, recent history of bacterial infection. The risk of long-term CVC infection was similar for tunneled catheters and venous access ports in each population.


Prevention of long-term CVC infection should focus first on better sterile precautions while handling long-term CVC, especially in HIV patients who have frequent and daily use of the long-term CVC.


Corresponding author

C-CLIN Paris Nord, Institut des Cordeliers, 15 rue de l'Ecole de Médecine, 75006 Paris, France


Hide All
1.Pittet, D. Nosocomial bloodstream infections. In: Wenzel, RP, ed. Prevention and Control of Nosocomial Infections. Baltimore, MD: Williams & Wilkins; 1997:711769.
2.Jarvis, WR, Edwards, JR, Culver, DH, Hughes, JM, Horan, T, Emori, TG, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infection Surveillance System. Am J Med 1991;91 (suppl 3B):185S191S.
3.Maki, DG. Infections due to infusion therapy. In: Bennett, JE, Brachman, PS, eds. Hospital Infections. Toronto, Ontario, Canada: Little Brown & Co; 1992:849898.
4.Hickman, RO, Buckner, CD, Clift, RA, Sanders, JE, Stewart, P, Thomas, ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871875.
5.Pearson, ML, the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravascular-device–related infections. Infect Control Hosp Epidemiol 1996;17:438473.
6.Raad, II, Bodey, GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15:197210.
7.Brun-Buisson, C, Abrouk, F, Legrand, P, Huet, Y, Larabi, S, Rapin, M. Diagnosis of central venous catheter-related sepsis. Arch Intern Med 1987;147:873877.
8.Douard, MC, Clementi, E, Arlet, G, Marie, O, Jacob, L, Schremmer, B, et al. Negative catheter-tip cultures and diagnosis of catheter-related bacteremia. Nutrition 1994;10:397404.
9.Raviglione, MC, Battan, R, Pablos-Mendez, A, Aceves-Casillas, P, Mullen, MP, Taranta, A. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med 1989;86:780786.
10.Singer, P, Rothkopf, MM, Kvetan, V, Kirvela, O, Gaare, J, Askanasi, J. Risks and benefits of home parenteral nutrition in the acquired immunodeficiency syndrome. Journal of Parenteral and Enteral Nutrition 1991;15:7579.
11.Skoutelis, AT, Murphy, RL, MacDonell, KB, VonRoenn, JH, Sterkel, CD, Phair, JP. Indwelling central venous catheter infections in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 1990;3:335342.
12.Sweed, M, Guenter, P, Lucente, K, Turner, JL, Weingarten, MS. Long-term central venous catheters in patients with acquired immunodeficiency syndrome. Am J Infect Control 1995;23:194199.
13.Stanley, HD, Charlebois, E, Harb, G, Jacobson, MA. Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease. J Acquir Immune Defic Syndr 1994;7:272278.
14.Skiest, DJ, Grant, P, Keiser, P. Nontunneled central venous catheters in patients with AIDS are associated with a low infection rate. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:220226.
15.Groeger, JS, Lucas, AB, Thaler, HT, Friedlander-Klar, H, Brown, AE, Kiehn, TE, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119:11681174.
16.Rotstein, C, Brock, L, Roberts, RS, Tech, M. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 1995;16:451458.
17.Timsit, JF, Sebille, V, Farkas, JC, Misset, B, Boyer, JM, Martin, JB, et al. Effect of subcutaneous tunneling of internal jugular catheters on catheter-related sepsis: a prospective randomized multicenter study. JAMA 1996;276:14161420.
18.Stroud, L, Srivastava, P, Culver, D, Culver, D, Bisno A Rimland, D, et al. Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995). Infect Control Hosp Epidemiol 1997;18:479485.
19.Cobb, DK, High, KP, Sawyer, RG, Sable, C, Adams, R, Lindley, D. A control trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992;327:10621068.

Long-Term Central Venous Catheter Infection in HIV-infected and Cancer Patients: A Multicenter Cohort Study

  • Pascal Astagneau (a1), Sylvie Maugat (a1), Tuan Tran-Minh (a1), Marie-Cécile Douard (a2), Pascale Longuet (a2), Caroline Maslo (a2), Régis Parte (a2), Annick Macrez (a2) and Gilles Brücker (a1) (a2)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed